Home / Growth Plan – Subscription Terms & Conditions
Growth Plan – Subscription Terms & Conditions
By subscribing to the Growth Plan, you agree to the following plan-specific terms. These apply in addition to the MAI CDMO Legal Terms.
With the Growth Plan you get:
Note: Access to the network and projects facilitates outreach but does not guarantee any response, lead volume, or awarded projects.
The Growth Plan is €49.99 per month, billed annually at a total of €599.88 VAT not included.
Available payment methods:
The subscription automatically renews at the end of each term unless cancelled by the subscriber at least thirty (30) days in advance.
Fees may be updated upon prior notice. If the subscriber does not accept the revised fee, it may cancel the subscription before the effective date.
The subscriber shall be responsible for keeping its contact details up to date.
In the event of non-payment, a grace period of forty-eight (48) hours shall be granted. If payment is not received in the provider’s account within this period, the subscription will automatically switch to the Basic Plan, with reduced features. This clause is established pursuant to the freedom of contract recognized in the Spanish Commercial Code (arts. 1 et seq.) and Civil Code (art. 1,261), as well as Law 7/1998, of April 13, on General Conditions of Contracting, last updated 16/03/2019, ensuring clarity, precision, and transparency for the parties.
2026-01-07
Pharmaron is a leading life sciences service provider, offering a wide range of research, development, and manufacturing capabilities across the entire drug discovery, preclinical, clinical development, and commercialization process.
See more
2025-11-05
Mabion is a CDMO company specializing in the advanced manufacturing and development of biological products, with extensive experience in monoclonal antibodies. Founded in 2007 and headquartered in the EU, in Poland.
See more
2025-10-15
Cultiply is a specialized biotechnology company dedicated to industrial microbiology and fermentation technologies for biological processes. This company is focused on offering a complete innovation platform, from the idea phase to industrial scaling.
See more
Adare Pharma is a global CDMO with sites in US and EU providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare s proprietary technology platforms specialize in ODT s, taste masking and customized drug release.
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Human, Veterinary
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Markets: DIGEMID (Peru), COFEPRIS (Mexico), INVIMA...
Tubilux Pharma: registered office; manufacturing facility
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Commercial (Phase IV), Human, Veterinary
Services: N/A
Batch Size / Reactor: Medium, Large
Certifications: EMA (EU GMP), FDA (cGMP), TGA (Australia GMP),...
Markets: FDA (USA), EMA (EU), TGA (Australia), ANVISA...
Cell Therapy company with excess Cleanroom capacity
Activity: FDF / DRUG PRODUCTS, BIOLOGICS, SERVICES manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Certifications: EMA (EU GMP)
Markets: EMA (EU)
Sterile manufacturing solutions (small molecules) in flexible bags and vials.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada...
Lannetts main manufacturing site sits in Seymour, Indiana, and includes capabilities for Oral Solid Dose (OSD) and Liquids.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Markets: COFEPRIS (Mexico), FDA (USA), EMA (EU), PMDA...
Reliable CDMO partner for aseptic manufacturing and lyophilization of biologics and injectable drugs.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services,...
Batch Size / Reactor: N/A
Certifications: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Markets: INVIMA (Colombia), FDA (USA), EMA (EU), MHRA (UK),...
Ophtalmic and Otic - Solutions, suspensions, emulsions, ointments and gels - FDA Approved facility
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Markets: FDA (USA), EMA (EU)
Commercial API Small Molecules Synthesis
Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, FDA (cGMP), ECOVADIS
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada...
If you have any questions or suggestions, click here. We will be happy to assist you.
